ES2155049T3 - Procedimiento para la fabricacion de un composicion biologicamente activa. - Google Patents
Procedimiento para la fabricacion de un composicion biologicamente activa.Info
- Publication number
- ES2155049T3 ES2155049T3 ES99927062T ES99927062T ES2155049T3 ES 2155049 T3 ES2155049 T3 ES 2155049T3 ES 99927062 T ES99927062 T ES 99927062T ES 99927062 T ES99927062 T ES 99927062T ES 2155049 T3 ES2155049 T3 ES 2155049T3
- Authority
- ES
- Spain
- Prior art keywords
- biologically active
- process according
- active agent
- carrier
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9801705 | 1998-05-14 | ||
| SE9801705A SE9801705D0 (sv) | 1998-05-14 | 1998-05-14 | Biologically active composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES2155049T1 ES2155049T1 (es) | 2001-05-01 |
| ES2155049T3 true ES2155049T3 (es) | 2004-05-16 |
Family
ID=20411319
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES99927062T Expired - Lifetime ES2155049T3 (es) | 1998-05-14 | 1999-05-12 | Procedimiento para la fabricacion de un composicion biologicamente activa. |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1077677B1 (https=) |
| JP (1) | JP2002514588A (https=) |
| KR (1) | KR100766998B1 (https=) |
| CN (1) | CN1309554A (https=) |
| AT (1) | ATE252371T1 (https=) |
| AU (1) | AU742921B2 (https=) |
| CA (1) | CA2332110A1 (https=) |
| DE (2) | DE69912271T2 (https=) |
| DK (1) | DK1077677T3 (https=) |
| ES (1) | ES2155049T3 (https=) |
| GR (1) | GR20010300014T1 (https=) |
| HU (1) | HUP0102002A3 (https=) |
| IL (2) | IL139577A0 (https=) |
| NO (1) | NO20005725L (https=) |
| NZ (1) | NZ508074A (https=) |
| PL (1) | PL344221A1 (https=) |
| SE (1) | SE9801705D0 (https=) |
| TR (1) | TR200003588T2 (https=) |
| WO (1) | WO1999058109A1 (https=) |
| ZA (1) | ZA200006476B (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003524652A (ja) * | 2000-02-29 | 2003-08-19 | ツァン，ツィエ | 改良された経皮薬剤パッチ |
| WO2005013939A1 (en) | 2003-08-06 | 2005-02-17 | Nirmal Mulye | Pharmaceutical composition containing water soluble drug |
| KR20090031726A (ko) | 2006-06-14 | 2009-03-27 | 닥터 레디스 레보러터리즈 리미티드 | 국소용 조성물 |
| WO2012028496A1 (de) * | 2010-08-31 | 2012-03-08 | Basf Se | Verzweigte polyester auf basis von zitronensäure sowie deren herstellung und verwendung |
| KR20140089478A (ko) * | 2011-01-13 | 2014-07-15 | 큐엘티 인코포레이티드 | 감광제의 국소 전달용 약학 조성물 및 그의 이용 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4940701A (en) * | 1984-01-25 | 1990-07-10 | Beecham Group P.L.C. | Topical drug release system |
| SE9502244D0 (sv) * | 1995-06-20 | 1995-06-20 | Bioglan Ab | A composition and a process for the preparation thereof |
| US5906830A (en) * | 1995-09-08 | 1999-05-25 | Cygnus, Inc. | Supersaturated transdermal drug delivery systems, and methods for manufacturing the same |
| GB2306885B (en) * | 1995-11-08 | 1999-07-14 | Reckitt & Colmann Prod Ltd | Supersaturated Pharmaceutical Compositions |
-
1998
- 1998-05-14 SE SE9801705A patent/SE9801705D0/xx unknown
-
1999
- 1999-05-12 IL IL13957799A patent/IL139577A0/xx active IP Right Grant
- 1999-05-12 NZ NZ508074A patent/NZ508074A/xx not_active IP Right Cessation
- 1999-05-12 DE DE69912271T patent/DE69912271T2/de not_active Expired - Lifetime
- 1999-05-12 HU HU0102002A patent/HUP0102002A3/hu unknown
- 1999-05-12 TR TR2000/03588T patent/TR200003588T2/xx unknown
- 1999-05-12 DE DE1077677T patent/DE1077677T1/de active Pending
- 1999-05-12 ES ES99927062T patent/ES2155049T3/es not_active Expired - Lifetime
- 1999-05-12 KR KR1020007012709A patent/KR100766998B1/ko not_active Expired - Fee Related
- 1999-05-12 JP JP2000547961A patent/JP2002514588A/ja active Pending
- 1999-05-12 WO PCT/SE1999/000824 patent/WO1999058109A1/en not_active Ceased
- 1999-05-12 CN CN99808549A patent/CN1309554A/zh active Pending
- 1999-05-12 EP EP99927062A patent/EP1077677B1/en not_active Expired - Lifetime
- 1999-05-12 PL PL99344221A patent/PL344221A1/xx unknown
- 1999-05-12 CA CA002332110A patent/CA2332110A1/en not_active Abandoned
- 1999-05-12 AT AT99927062T patent/ATE252371T1/de active
- 1999-05-12 AU AU44051/99A patent/AU742921B2/en not_active Ceased
- 1999-05-12 DK DK99927062T patent/DK1077677T3/da active
-
2000
- 2000-11-09 IL IL139577A patent/IL139577A/en not_active IP Right Cessation
- 2000-11-09 ZA ZA200006476A patent/ZA200006476B/xx unknown
- 2000-11-13 NO NO20005725A patent/NO20005725L/no not_active Application Discontinuation
-
2001
- 2001-04-30 GR GR20010300014T patent/GR20010300014T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0102002A3 (en) | 2002-12-28 |
| HUP0102002A2 (hu) | 2002-03-28 |
| ATE252371T1 (de) | 2003-11-15 |
| CA2332110A1 (en) | 1999-11-18 |
| DK1077677T3 (da) | 2004-02-16 |
| JP2002514588A (ja) | 2002-05-21 |
| TR200003588T2 (tr) | 2001-06-21 |
| IL139577A0 (en) | 2002-02-10 |
| SE9801705D0 (sv) | 1998-05-14 |
| EP1077677B1 (en) | 2003-10-22 |
| GR20010300014T1 (en) | 2001-04-30 |
| AU742921B2 (en) | 2002-01-17 |
| ZA200006476B (en) | 2001-06-11 |
| WO1999058109A1 (en) | 1999-11-18 |
| ES2155049T1 (es) | 2001-05-01 |
| KR100766998B1 (ko) | 2007-10-15 |
| AU4405199A (en) | 1999-11-29 |
| NZ508074A (en) | 2003-01-31 |
| DE69912271D1 (de) | 2003-11-27 |
| CN1309554A (zh) | 2001-08-22 |
| DE69912271T2 (de) | 2004-08-26 |
| NO20005725L (no) | 2001-01-11 |
| KR20010052349A (ko) | 2001-06-25 |
| EP1077677A1 (en) | 2001-02-28 |
| DE1077677T1 (de) | 2001-09-20 |
| PL344221A1 (en) | 2001-10-08 |
| NO20005725D0 (no) | 2000-11-13 |
| IL139577A (en) | 2007-07-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Chen et al. | Electroporation-enhanced transdermal drug delivery: Effects of logP, pKa, solubility and penetration time | |
| ES2340732T3 (es) | Sistema terapeutico transdermico que contiene particulas de una sustancia activa, con un flujo aumentado de la sustancia activa. | |
| WO2012130336A1 (en) | Delivery of large molecular weight biologically active substances | |
| CN111407721B (zh) | 一种促进活性成分渗透皮肤的体系 | |
| Pansuriya et al. | Multifunctional ionic hydrogel-based transdermal delivery of 5-fluorouracil for the breast cancer treatment | |
| ES2155049T3 (es) | Procedimiento para la fabricacion de un composicion biologicamente activa. | |
| Bhavsar et al. | Strategies for transportation of peptides across the skin for treatment of multiple diseases | |
| WO2016024855A1 (es) | Composición farmaceutica en emulgel de ivermectina para uso veterinario como sistema promotor y bioadhesivo en el tratamiento antiparasitario, y metodo para obtener la misma | |
| AU736480B2 (en) | Biologically active composition | |
| Mukherjee et al. | Transdermal Nanomedicines for Reduction of Dose and Site-Specific Drug Delivery | |
| CN103100088B (zh) | 一种高分子透皮吸收促进剂及其制备方法和应用 | |
| Gupta et al. | Penetration enhancers: Role in transdermal drug delivery system | |
| Parihar et al. | Soft malleable vesicles tailored for enhanced delivery of active agents through the skin: an update | |
| Tigote et al. | Comprehensive review on ethosomes: a novel vesicular approach for topical drug delivery | |
| MXPA00011077A (en) | Biologically active composition | |
| CN111991371B (zh) | 一种gsh浓度响应性治疗甲状腺功能亢进的药质体水凝胶贴剂及其制备方法 | |
| Nabila et al. | Third Generation Ionic Liquids and Deep Eutectic Solvents in Advanced Transdermal Drug Delivery | |
| CZ20004128A3 (cs) | Biologicky aktivní prostředek a způsob jeho přípravy | |
| CZ20004127A3 (cs) | Biologicky aktivní prostředek a způsob jeho přípravy | |
| TR2022020852A2 (tr) | Propoli̇s ve dekspantenol nanoemülsi̇yonlarini i̇çeren hi̇drojel ve organojel formülasyonlari | |
| Kameswararao et al. | A Brief Review on Emulgels | |
| Al-Fagih | Transdermal Delivery System of Testosterone Using Solid Lipid Particles | |
| JP2001061973A (ja) | イオントフォレーシス用医薬組成物 |